Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-20 | Allene M. Diaz, age 57, has served as a Director of Ionis since June 2021. ... Ms. Diaz has served on the boards of directors of Mersana Therapeutics since March 2021, Allena Pharmaceuticals since April 2019 and BCLS Acquisition Corporation since October 2020. ... The Board believes Ms. Diaz is uniquely suited to serve on the Board primarily because of her deep expertise in product development, commercial strategy, market access, and portfolio management. ... Ms. Diaz was appointed to the Board in June 2021. ... Ms. Diaz was appointed to the Board in June 2021. ... The table shows for the fiscal year ended December 31, 2021 certain information with respect to the compensation of our Directors: ... Allene M. Diaz: Cash Compensation $35,000, Stock Awards $285,360, Option Awards $409,860, Total $730,220. |
| 2024-04-25 | Allene M. Diaz, age 59, has served as a Director of Ionis since June 2021. Ms. Diaz has deep expertise in product development, commercial strategy, market access, and portfolio management. She serves on the Audit and Compliance Committees. Ms. Diaz received total compensation of $530,038 in 2023. |
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-27 | "Ms. Diaz’s experience in the commercial development and program strategy for oncology assets and her executive leadership and business experience in the biotechnology sector qualifies her to serve as a member of our Board of Directors." |
| 2022-04-29 | "Ms. Diaz earned a B.S. in Psychology from Florida State University. We believe that Ms. Diaz’s experience in the commercial development and program strategy for oncology assets and her executive leadership and business experience in the biotechnology sector qualifies her to serve as a member of our Board of Directors." |
| 2023-04-28 | "Ms. Diaz received a B.S. in psychology from Florida State University. We believe that Ms. Diaz’s experience in the commercial development and program strategy for oncology assets and her executive leadership and business experience in the biotechnology sector qualifies her to serve as a member of our Board of Directors." |
| 2024-04-26 | "Ms. Diaz has led AMD Consulting, a new product strategy and portfolio management consulting practice... She received a B.S. in psychology from Florida State University." |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-07-06